Related Experiment Video
Updated: Oct 9, 2026

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
Published on: August 18, 2014
Prejunctional actions of N-ethyl-maleimide and phenoxybenzamine in rat vas deferens
Abstract:
In studies of electrically evoked isometric contractions of rat vas deferens, N-ethyl-maleimide (30 microM) pretreatment significantly reduced the prejunctional inhibitory potencies of xylazine and 5-hydroxytryptamine but failed to affect the potency of the alpha 1-adrenoceptor agonist amidephrine. Phenoxybenzamine (1 microM) or N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (10 microM) produced significant shifts in the potency of xylazine and significantly reduced the maximum inhibition, but the combination of phenoxybenzamine or EEDQ and N-ethyl-maleimide (30 microM) produced no further alteration in the effects of xylazine. In displacement studies, N-ethyl-maleimide displaced the binding of [3H]MK 912 ((2S,12bS)1',3'-dimethylspiro- (1,3,4,5',6,6',7,12b-octahydro-2H-benzo[b]furo[2,3-a]quinazoline)- 2,4'- pyrimidin-2'one) to rat renal cortex membranes with a Ki of 466 +/- 133 microM (n = 5), and so does not bind to alpha 2-adrenoceptors in the concentration range in which it affects prejunctional receptor mediated responses. This may suggest that N-ethyl-maleimide has actions other than inactivation of G-proteins or that the irreversible alpha 2-adrenoceptor antagonists phenoxybenzamine and EEDQ inactivate G-proteins sensitive to N-ethyl-maleimide in concentrations at which they bind to alpha 2-adrenoceptors.
Insights
N-ethyl-maleimide affects prejunctional receptors in rat vas deferens by mechanisms beyond G-protein inactivation, as shown by its distinct effects compared to alpha 2-adrenoceptor antagonists.
Area of Science:
- Pharmacology
- Neuroscience
- Physiology
Background:
- Prejunctional receptors modulate neurotransmitter release.
- Alpha-2 adrenoceptors and serotonin receptors play roles in regulating smooth muscle contraction.
- N-ethyl-maleimide is a chemical agent used to probe protein function.
Purpose of the Study:
- To investigate the mechanism of action of N-ethyl-maleimide on prejunctional inhibitory receptors.
- To differentiate the effects of N-ethyl-maleimide from known alpha-2 adrenoceptor antagonists.
Main Methods:
- Electrically evoked isometric contractions of rat vas deferens.
- Pretreatment with N-ethyl-maleimide, phenoxybenzamine, or EEDQ.
- Receptor binding assays using [3H]MK 912.
Main Results:
- N-ethyl-maleimide reduced the potency of xylazine and 5-hydroxytryptamine but not amidephrine.
- Phenoxybenzamine and EEDQ altered xylazine's effects, but N-ethyl-maleimide did not further modify these.
- N-ethyl-maleimide did not bind to alpha-2 adrenoceptors at effective concentrations.
Conclusions:
- N-ethyl-maleimide's effects on prejunctional receptors may involve mechanisms other than direct G-protein inactivation.
- The findings suggest a complex interplay between N-ethyl-maleimide, G-proteins, and alpha-2 adrenoceptors.
More Related Videos
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
09:47Measurement of Endothelium-Dependent Vasorelaxation in the Mouse Thoracic Aorta Using Tensometric Small Volume Chamber Myography
Published on: August 12, 2022
Related Concept Videos
Nitric Oxide Signaling Pathway
Drugs Affecting Neurotransmitter Release or Uptake
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Antihypertensive Drugs: Vasodilators